Autopsy report · NCT01422343

Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease

“Shortage of personnel / main study initiator no longer available”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Insel Gruppe AG, University Hospital Bern

Sponsor type

University, hospital or other

Conditions

Peripheral Vascular Diseases

Interventions

percutaneous transluminal angioplasty femoro-popliteal

Participants

0

Trials that died the same way

• The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression
  “the study has stopped due to no recruitment” (66% match in meaning)
• Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
  “Study stopped due to difficulties in patient recruitment” (64% match in meaning)
• A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
  “The study was ended due to a lack of recruitment” (64% match in meaning)
• Hypoxia and Heart Rate Variability
  “Study stopped due to no recruitment activities” (62% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.